Ariela Maína Boeder

Ariela Maína Boeder

Auto-generated profile, based on publicly available information

Ariela Maína Boeder

Department of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2017 in Journal of Apicultural Research
Verified
Journal Article
Closed access
LSLarissa dos Santos
Larissa dos Santos
SHSabrina Hochheim
Sabrina Hochheim
ABAriela Maína Boeder
Ariela Maína Boeder
AKAline Kroger
Aline Kroger
MTMaíra Maciel Tomazzoli
Maíra Maciel Tomazzoli
CCCaio M M de Cordova
Caio M M de Cordova

19 April 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
TSTomas A. Schiffer
Tomas A. Schiffer
LCLucas Rannier Ribeiro Antonino Carvalho
Lucas Rannier Ribeiro Antonino Carvalho
DGDrielle Guimaraes
Drielle Guimaraes
ABAriela Boeder
Ariela Boeder
PWPer Ingvar, Oskar Wikström
Per Ingvar, Oskar Wikström
Mattias CarlstromMattias Carlstrom
Mattias Carlstrom
Background: Acute kidney injury (AKI) is a sudden episode of kidney failure which is frequently observed at intensive care units and related to high morbidity/mortality. Although AKI can have many different causes, ischemia–reperfusion (IR) injury is the main cause of AKI. Mechanistically, NADPH oxidases (NOXs) are involved in the pathophysiology contributing to oxidative stress following IR. Previous reports have indicated that knockout of NOX4 may offer protection in cardiac and brain IR, but there is currently less knowledge about how this could be exploited therapeutically and whether this could have significant protection in IR-induced AKI. Aim: To investigate the hypothesis that a novel and specific NOX4 inhibitor (GLX7013114) may have therapeutic potential on kidney and mitochondrial function in a mouse model of IR-induced AKI. Methods: Kidneys of male C57BL/6J mice were clamped for 20 min, and the NOX4 inhibitor (GLX7013114) was administered via osmotic minipump during reperfusion. Following 3 days of reperfusion, kidney function (i.e., glomerular filtration rate, GFR) was calculated from FITC-inulin clearance and mitochondrial function was assessed by high-resolution respirometry. Renal histopathological evaluations (i.e., hematoxylin–eosin) and TUNEL staining were performed for apoptotic evaluation. Results: NOX4 inhibition during reperfusion significantly improved kidney function, as evidenced by a better-maintained GFR (p < 0.05) and lower levels of blood urea nitrogen (p < 0.05) compared to untreated IR animals. Moreover, IR caused significant tubular injuries that were attenuated by simultaneous NOX4 inhibition (p < 0.01). In addition, the level of renal apoptosis was significantly reduced in IR animals with NOX4 inhibition (p < 0.05). These favorable effects of the NOX4 inhibitor were accompanied by enhanced Nrf2 Ser40 phosphorylation and conserved mitochondrial function, as evidenced by the better-preserved activity of all mitochondrial complexes. Conclusion: Specific NOX4 inhibition, at the time of reperfusion, significantly preserves mitochondrial and kidney function. These novel findings may have clinical implications for future treatments aimed at preventing AKI and related adverse events, especially in high-risk hospitalized patients.

1 November 2015 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
ÉBÉverson Miguel Bianco
Éverson Miguel Bianco
JKJéssica Lenita Krug
Jéssica Lenita Krug
PZPriscila Laiz Zimath
Priscila Laiz Zimath
AKAline Kroger
Aline Kroger
CPCamila Jeriane Paganelli
Camila Jeriane Paganelli
RRRicardo Andrade Rebelo
Ricardo Andrade Rebelo
This work describes the antimicrobial, antioxidant and anticholinesterase activities in vitro of organic extracts from fourteen seaweeds, eleven sponges, two ascidians, one bryozoan, and one sea anemone species collected along the Brazilian and Spanish coast, as well as the isolation of the diterpene (4R, 9S, 14S)-4α-acetoxy-9β,14α-dihydroxydolast-1(15),7-diene (1) and halogenated sesquiterpene elatol (2). The most promising antimicrobial results for cell wall bacteria were obtained by extracts from seaweeds Laurencia dendroidea and Sargassum vulgare var. nanun (MIC 250μg/ml), and by the bryozoan Bugula neritina (MIC 62.5μg/ml), both against Staphylococcus aureus. As for antimollicutes, extracts from seaweeds showed results better than the extracts from invertebrates. Almost all seaweeds assayed (92%) exhibited some antimicrobial activity against mollicutes strains (Mycoplasma hominis, Mycoplasma genitalium, Mycoplasma capricolum and Mycoplasma pneumoniae strain FH). From these seaweeds, A1 (Canistrocarpus cervicornis), A11 (Gracilaria sp.) and A4 (Lobophora variegata) showed the best results for M. pneumoniae strain FH (MIC 250μg/ml). Furthermore, compounds 1 and 2 were also assayed against mollicutes strains M. hominis, M. genitalium, M. capricolum, M. pneumoniae strain 129 and M. pneumoniae strain FH, which showed MIC>100μg/ml. Antioxidant activities of extracts from these marine organisms were inactive, except for E7 (from sponge Ircinia sp.), which exhibited moderated antioxidant activities for two methods assayed (IC50 83.0±0.1μg/ml, and 52.0±0.8mg AA/g, respectively). Finally, for the anticholinesterase activity, all the 29 samples evaluated (100%) exhibited some level of activity, with IC50<1000μg/ml. From these, seaweeds extracts were considered more promising than marine invertebrate extracts [A10 (IC50 14.4±0.1μg/ml), A16 (IC50 16.4±0.4μg/ml) and A8 (IC50 14.9±0.5μg/ml)]. The findings of this work are useful for further research aiming at isolation and characterization of active compounds

17 October 2017 in Journal of Medicinal Plants Research
Verified
Journal Article
Open access
PDF file
TATenfen Adrielli
Tenfen Adrielli
MAM. Boeder Ariela
M. Boeder Ariela
CCC. Bella-Cruz Catarina
C. Bella-Cruz Catarina
BABella-Cruz Alexandre
Bella-Cruz Alexandre
MCM. M. Córdova Caio
M. M. Córdova Caio
VFValdir Cechinel Filho
Valdir Cechinel Filho
The aim of this study was to evaluate the chemical composition and antimicrobial activity of four unexplored Eugenia species: Eugenia brevistyla, Eugenia handroana, Eugenia catharinae and Eugenia stigmatosa. Eight extracts and eighteen fractions were screened for their antibacterial activity against some selected bacteria including Mycoplasma. Phytochemical screening revealed that the plants were rich in terpenes and phenolic compounds. Antimicrobial evaluation revealed that E. handroana (FAEF-EH) and E. brevistyla (FAEF-EB) had the highest activity against Staphylococcus aureus with minimum inhibitory concentration (MIC) of 15.62 µg/ml Mycoplasma while FAEF-EH also presented the best activity with MIC of 62.5 µg/ml against Mycoplasma pneumonia M129. Some isolated compounds, betulinic acid and glutinol, also exhibited antibacterial property against some bacteria used in the study. All the four species studied presented promising antibacterial activity while the active principles are yet to be elucidated. Key words: Eugenia handroana, Eugenia brevistyla, Eugenia catharinae, Eugenia stigmatosa, antibacterial activity, antimycoplasma activity.

13 October 2025 in Acta Physiologica
Verified
Journal Article
Open access
MSMiho Shimari
Miho Shimari
GPGaia Picozzi
Gaia Picozzi
ABAriela Boeder
Ariela Boeder
DGDrielle Dantas Guimarães
Drielle Dantas Guimarães
ZZZhengbing Zhuge
Zhengbing Zhuge
GPGianluigi Pironti
Gianluigi Pironti
Aims: Impaired cardiac function, reduced nitric oxide (NO) bioavailability, and inflammation are key contributors to the pathogenesis and progression of heart failure with reduced ejection fraction (HFrEF). This study aimed to investigate whether dietary inorganic nitrate supplementation can attenuate cardiac dysfunction and adverse remodeling in HFrEF by enhancing NO signaling. Methods: Two mouse models of HFrEF, induced by myocardial infarction (MI) or transverse aortic constriction (TAC), were treated with dietary nitrate or a control diet for 4–6 weeks, initiating the treatment on day 3 after myocardial injury. Echocardiography and pressure volume (PV) loop analysis were employed to assess cardiac function and hemodynamics. Histology staining was performed to assess the degree of cardiac fibrosis. Myograph experiments were conducted to assess aortic vasorelaxation. Biomarkers related to hypertrophy, fibrosis, and inflammation were analyzed in cardiac tissues through Q‐PCR analysis and immunofluorescence staining. Results: In HFrEF mice, long‐term inorganic nitrate treatment increased systolic and diastolic function, enhanced vascular relaxation, and reduced both replacement and reactive fibrosis. In the nitrate group, cardiac gene expression showed downregulation of hypertrophy‐, fibrosis‐, and inflammation‐related markers, alongside upregulation of anti‐inflammatory markers associated with M1‐to‐M2 macrophage polarization. Immunofluorescence confirmed reduced fibrosis and increased anti‐inflammatory protein biomarkers associated with increased serum nitrate and cardiac cGMP levels. Conclusions: Early initiation of dietary nitrate supplementation after myocardial injury enhances cardiac and vascular function, reduces fibrosis and inflammation, and holds promise as a cardioprotective strategy to reduce the progression of HFrEF through NO‐signaling.